Clinical Analysis of Stage I and II Breast Cancer.
- Author:
Young Up CHO
1
;
Young Bae KO
;
Sei Woong KIM
;
Sei Joong KIM
;
Ki Seog LEE
;
Seck Hwan SHIN
;
Kyung Rae KIM
Author Information
1. Department of Surgery, Inha Hospital, Inha University College of Medicine, Seongnam, Korea.
- Publication Type:Original Article
- Keywords:
Stage I and II;
Breast cancer;
Surgery;
Systemic therapy
- MeSH:
Breast Neoplasms*;
Breast*;
Drug Therapy;
Hospitals, Community;
Hospitals, University;
Humans;
Mastectomy;
Mastectomy, Modified Radical;
Mastectomy, Radical;
Mastectomy, Simple;
Radiotherapy;
Retrospective Studies
- From:Journal of the Korean Surgical Society
2001;61(1):33-39
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The combination of conservative surgery and radiotherapy is currently accepted as the preferred treatment for most patents with clinical stage I or II breast cancer. However, there is large amount of controversy concerning the optimal means of selecting patients and the details of the treatment technique. Breast cancer patients are being treated both in university hospitals and in community hospitals. Generally, the radiation therapy is not available in many community hospitals. Radiation therapy, which generally follows either a mastectomy or conservative surgery, is an important procedure. Therefore, the type of hospital facilities may influence which surgical procedures are selected. The authors conducted this study to analyse the current patterns of care for early invasive breast cancer in a hospital without a radiation therapy unit, even though the patient could receive such treatment from another affiliated hospital. METHODS: 131 cases of stage I and II breast cancer patients were reviewed between 1987 and 1997, and the types of treatments including surgery, radiation therapy and systemic therapy, were analysed retrospectively. RESULTS: The surgical procedures used were mainly a modified radical mastectomy (124/131, 94.7%), followed by breast conservation surgery (4/131, 3.1%), a total mastectomy (2/131, 1.5%) and a radical mastectomy (1/131, 0.8%). Radiation therapy was applied to 19 stage II patients (N=105), but not to any of the stage I patients (N=26). Systemic adjuvant therapy was done with chemotherapy (39/131, 29.8%), hormone therapy (17/131, 13.0%) and a combination of both modalities (67/131, 51.1%), with an exception of 8 cases. CONCLUSION: Breast conservation therapy for breast cancer patients was underutilized. The selection of the therapeutic method may be influenced by the facilities of the particular hospital. For proper treatment of early stage breast cancer, a surgeon must keep in close contact with bothe a radiologist and a radiotherapist, even in other affiliated hospitals.
